This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HH&L Acquisition Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
HH&L Acquisition Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
DiaCarta Inc. cancelled the acquisition of HH&L Acquisition Co. in a reverse merger transaction. CI
HH&L Acquisition Co. announced that it expects to receive $3 million in funding CI
HH&L Acquisition Co. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
HH&L Acquisition Co. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
HH&L Acquisition Co. Auditor Raises 'Going Concern' Doubt CI
DiaCarta Gets FDA Authorization for Monkeypox Test Kit DJ
HH&L Acquisition Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
HH&L Acquisition to Merge with DiaCarta MT
DiaCarta Inc. agreed to acquire HH&L Acquisition Co. for approximately $460 million. CI
HH&L Acquisition Co. announced that it expects to receive $0.5 million in funding from Hh&L Investment Co CI
HH&L Acquisition Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
HH&L Acquisition Co. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
HH&L Acquisition Co. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
HH&L Acquisition Co. Auditor Raises 'Going Concern' Doubt CI
Hh&L Acquisition Co. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Certain Class B Ordinary Shares of HH&L Acquisition Co. are subject to a Lock-Up Agreement Ending on 4-AUG-2021. CI
HH&L Acquisition Co. Announces Appointments CI
HH&L Acquisition Co. has completed an IPO in the amount of $360 million. CI
HH&L Acquisition Co. has filed an IPO in the amount of $300 million. CI
Chart HH&L Acquisition Co.
More charts
HH&L Acquisition Co is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to acquire one or more healthcare businesses, with a focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW